2022. Overview of the advantages and disadvantages of chimeric antigen receptor T cell therapy in the tumor microenvironment. Biomedical Research and Therapy. 9, 10 (Oct. 2022), 5341–5350. DOI:https://doi.org/10.15419/bmrat.v9i10.772.